Polygodial, a drimane sesquiterpenoid dialdehyde purified from Drimys winteri, inhibits voltage-gated sodium channels

Nat Prod Res. 2022 Dec;36(24):6318-6323. doi: 10.1080/14786419.2022.2025592. Epub 2022 Jan 13.

Abstract

Drimys winteri J.R.Forst. & G.Forst, a South American evergreen shrub that is used by the Mapuche people for treatment of several painful conditions, contains polygodial, a lipophilic drimane-type sesquiterpene dialdehyde with known activity at transient receptor potential channel family members including TRPA1 and TRPV1. We sought to assess the activity of polygodial at NaV1.7 and NaV1.8, two key isoforms of the voltage-gated sodium channel family involved in nociception. Polygodial was isolated from D. winteri by thin-layer chromatography and analysed structurally by 1 D and 2 D nuclear magnetic resonance (NMR) spectroscopy. Activity at heterologously expressed NaV1.7 and NaV1.8 was assessed using automated whole-cell patch-clamp electrophysiology. Here, we show that polygodial inhibits members of the voltage-gated sodium channel family, specifically NaV1.7 and NaV1.8, without changing the voltage-dependence of activation or inactivation. Activity of polygodial at voltage-gated sodium channels may contribute to the previously reported antinociceptive properties.

Keywords: NaV1.7; NaV1.8; Polygodial; analgesia; patch-clamp.

MeSH terms

  • Drimys*
  • Humans
  • Sesquiterpenes* / pharmacology
  • Voltage-Gated Sodium Channels*

Substances

  • drimane
  • polygodial
  • Voltage-Gated Sodium Channels
  • Sesquiterpenes